Aktis Oncology (AKTS, $26.56) Moving Average Convergence Divergence (MACD) Histogram turned negative on July 7, 2026

#Biotechnology, #TechnicalAnalysis, #MACD, #Bearish, #Stocks, #SmallCap, #Russel2000
AKTS - Aktis Oncology Inc
MACD signal
Bearish Trend
90%
Odds of DOWN Trend
Price: $26.56
Daily change: $0 (0%)
Daily volume: 482.7K
Capitalization: $1.5B
Industry: Biotechnology

This is a Bearish indicator signaling AKTS's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 32 similar cases where AKTS's MACD histogram became negative, and 32 of them led to successful outcomes. Odds of Success: 90%.